17 Million for Future Cancer Diagnoses

08:05 EDT 7 Aug 2019 | Bionity

image description
After a successful market entry in the DACH Region (Germany, Austria and Switzerland) and the opening of a subsidiary office in Krakow, Poland, inveox continues to grow. With its largest investment so far of 17 million euros, the Munich startup will begin the series-level production of their AI-supp...

Original Article: 17 Million for Future Cancer Diagnoses

More From BioPortfolio on "17 Million for Future Cancer Diagnoses"